Qingqi Meng

1.1k total citations
59 papers, 764 citations indexed

About

Qingqi Meng is a scholar working on Molecular Biology, Rheumatology and Plant Science. According to data from OpenAlex, Qingqi Meng has authored 59 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Rheumatology and 8 papers in Plant Science. Recurrent topics in Qingqi Meng's work include Osteoarthritis Treatment and Mechanisms (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Natural product bioactivities and synthesis (6 papers). Qingqi Meng is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Natural product bioactivities and synthesis (6 papers). Qingqi Meng collaborates with scholars based in China, Japan and Germany. Qingqi Meng's co-authors include Yue Hou, Ning Li, Di Zhou, Xingliang Zhang, Pengzhen Wang, Haifeng Zhang, Yan Mi, Shaoheng Zhang, Jingyu Liu and Siming Li and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Qingqi Meng

58 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingqi Meng China 16 371 131 112 87 83 59 764
Congrui Liao China 11 437 1.2× 77 0.6× 105 0.9× 100 1.1× 31 0.4× 16 886
Daohua Xu China 17 550 1.5× 116 0.9× 77 0.7× 67 0.8× 30 0.4× 39 948
Sungmi Park South Korea 17 397 1.1× 118 0.9× 39 0.3× 88 1.0× 61 0.7× 38 1.0k
Chongan Huang China 18 419 1.1× 118 0.9× 206 1.8× 61 0.7× 59 0.7× 35 1.0k
Hsiang‐Ping Lee Taiwan 15 300 0.8× 101 0.8× 149 1.3× 91 1.0× 51 0.6× 16 682
Li Pang China 17 336 0.9× 143 1.1× 51 0.5× 93 1.1× 89 1.1× 55 794
Mingbao Song China 20 448 1.2× 99 0.8× 59 0.5× 78 0.9× 79 1.0× 39 1.2k
Qiaoke Gong United States 16 294 0.8× 79 0.6× 91 0.8× 59 0.7× 71 0.9× 26 918
Huihui Huang China 17 337 0.9× 100 0.8× 30 0.3× 89 1.0× 51 0.6× 30 849

Countries citing papers authored by Qingqi Meng

Since Specialization
Citations

This map shows the geographic impact of Qingqi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqi Meng more than expected).

Fields of papers citing papers by Qingqi Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqi Meng. The network helps show where Qingqi Meng may publish in the future.

Co-authorship network of co-authors of Qingqi Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqi Meng. A scholar is included among the top collaborators of Qingqi Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqi Meng. Qingqi Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Qingqi, Yan Mi, Libin Xu, et al.. (2025). A quinolinyl analog of resveratrol improves neuronal damage after ischemic stroke by promoting Parkin-mediated mitophagy. Chinese Journal of Natural Medicines. 23(2). 214–224. 1 indexed citations
2.
Meng, Qingqi, Qing Liu, Mi Yan, et al.. (2025). Multi-dimensional data-driven computational drug repurposing strategy for screening novel neuroprotective agents in ischemic stroke. Theranostics. 15(15). 7653–7676. 1 indexed citations
4.
Liu, Yeshu, Yanqiu Yang, Yan Mi, et al.. (2024). Americanin B inhibits pyroptosis in lipopolysaccharide-induced septic encephalopathy mice through targeting NLRP3 protein. Phytomedicine. 128. 155520–155520. 6 indexed citations
5.
Liu, Jingyu, et al.. (2024). Biomimetic cell membrane vesicles as promising delivery carriers for dietary polyphenols in neurodegenerative diseases. Journal of Drug Delivery Science and Technology. 93. 105418–105418. 4 indexed citations
6.
Wang, Yingjie, Gang Chen, Di Zhou, et al.. (2024). Chemical profile of the roots of Clausena lansium and their inhibitory effects of the over-activation in BV-2 microglial cells. Phytochemistry. 220. 114008–114008. 6 indexed citations
7.
Chen, Junjie & Qingqi Meng. (2024). Causal Role of Oxidative Stress-Related Genes in Osteoarthritis. 8(3). 28–31. 1 indexed citations
8.
Liu, Ruijia, et al.. (2023). Crowned dens syndrome: A rare form of acute neck pain and headache that can be misdiagnosed or missed. The American Journal of Emergency Medicine. 70. 209.e1–209.e3. 3 indexed citations
9.
Wang, Yingjie, Qingqi Meng, Gang Chen, et al.. (2023). Potential inhibitors of microglial activation from the roots of Wikstroemia lichiangensis W. W. Sm. Phytochemistry. 213. 113767–113767. 3 indexed citations
10.
Huang, Jian, et al.. (2023). Enhanced recovery after surgery combined with quantitative rehabilitation training in early rehabilitation after total knee replacement: a randomized controlled trial. European Journal of Physical and Rehabilitation Medicine. 60(1). 74–83. 8 indexed citations
11.
Zhang, Liubo, Lu Zhang, Yan Wang, et al.. (2023). Coexistence of diffuse large B-cell lymphoma, acute myeloid leukemia, and untreated lymphoplasmacytic lymphoma/waldenström macroglobulinemia in a same patient: A case report. World Journal of Clinical Cases. 11(18). 4295–4305. 1 indexed citations
12.
Xue, Xiang, Zhenyu Yang, Pengfei Xu, et al.. (2023). SCP2 mediates the transport of lipid hydroperoxides to mitochondria in chondrocyte ferroptosis. Cell Death Discovery. 9(1). 234–234. 16 indexed citations
13.
Huang, Qiuxiang, et al.. (2023). PPAR-γ Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1α/Δψm Pathways by Inhibiting Pyroptosis. PPAR Research. 2023. 1–19. 22 indexed citations
14.
Wang, Yingjie, Di Zhou, Qingqi Meng, et al.. (2022). Anti-neuroinflammatory effects in vitro and in vivo, and chemical profile of Jatropha curcas L. Bioorganic Chemistry. 122. 105720–105720. 7 indexed citations
15.
Guo, Tingting, Yaping Zhou, Di Zhou, et al.. (2022). Sesquiterpene coumarins isolated from Ferula bungeana and their anti-neuroinflammatory activities. Bioorganic Chemistry. 128. 106102–106102. 10 indexed citations
16.
Wang, Wen, Shengnan Qin, Liang Chen, et al.. (2021). Type II Collagen Sponges Facilitate Tendon Stem/Progenitor Cells to Adopt More Chondrogenic Phenotypes and Promote the Regeneration of Fibrocartilage-Like Tissues in a Rabbit Partial Patellectomy Model. Frontiers in Cell and Developmental Biology. 9. 682719–682719. 7 indexed citations
17.
Wang, Yingjie, Gang Chen, Qingqi Meng, et al.. (2021). Potential inhibitors of microglial activation from the roots of Vernicia montana Lour. Phytochemistry. 194. 113019–113019. 3 indexed citations
18.
Huang, Jianwen, et al.. (2021). Primary hyperphosphatemic tumoral calcinosis: a case report. Osteoporosis International. 33(1). 309–312. 2 indexed citations
19.
Meng, Qingqi, et al.. (2018). Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury. PPAR Research. 2018. 1–11. 10 indexed citations
20.
Meng, Qingqi, et al.. (2011). Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. Neuroscience Letters. 503(3). 191–195. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026